LOCV calculation for Beta-stable matter at finite temperature

The method of lowest-order constrained variational, which predicts reasonably the nuclear matter semi-empirical data is used to calculate the equation of state of beta-stable matter at finite temperature. The Reid soft-core with and without the N-$\Delta$ interactions which fits the N-N scattering data as well as the $UV_{14}$ potential plus the three-nucleon interaction are considered in the nuclear many-body Hamiltonian. The electron and muon are treated relativistically in the total Hamiltonian at given temperature, to make the fluid electrically neutral and stable against beta decay. The calculation is performed for a wide range of baryon density and temperature which are of interest in the astrophysics. The free energy, entropy, proton abundance, etc. of nuclear beta-stable matter are calculated. It is shown that by increasing the temperature, the maximum proton abundance is pushed to the lower density while the maximum itself increases as we increase the temperature. The proton fraction is not enough to see any gas-liquid phase transition. Finally we get an overall agreement with other many-body techniques, which are available only at zero temperature.Comment: LaTex, 20 page

The general behavior of NLONLO unintegrated parton distributions based on the single-scale evolution and the angular ordering constraint

To overcome the complexity of generalized two hard scale ($k_t$,$\mu$) evolution equation, well known as the $Ciafaloni$, $Catani$, $Fiorani$ and $Marchsini$ ($CCFM$) evolution equations, and calculate the unintegrated parton distribution functions ($UPDF$), $Kimber$, $Martin$ and $Ryskin$ ($KMR$) proposed a procedure based on ($i$) the inclusion of single-scale ($\mu$) only at the last step of evolution and ($ii$) the angular ordering constraint ($AOC$) on the $DGLAP$ terms (the $DGLAP$ collinear approximation), to bring the second scale, $k_t$ into the $UPDF$ evolution equations. In this work we intend to use the $MSTW 2008$ (Martin et al) parton distribution functions (PDF) and try to calculate $UPDF$ for various values of $x$ (the longitudinal fraction of parton momentum), $\mu$ (the probe scale) and $k_t$ (the parton transverse momentum) to see the general behavior of three dimensional $UPDF$ at the $NLO$ level up to the $LHC$ working energy scales ($\mu^2)$. It is shown that there exits some pronounced peaks for the three dimensional $UPDF$ $(f_a(x,k_t))$ with respect to the two variables $x$ and $k_t$ at various energies ($\mu$). These peaks get larger and move to larger values of $k_t$, as the energy ($\mu$) is increased. We hope these peaks could be detected in the $LHC$ experiments at $CERN$ and other laboratories in the less exclusive processes

Macular thickness measurement in clinically significant macular edema before and after meal

Purpose: To evaluate the macular thickness changes in diabetic macular edema after meal. Methods: In this prospective case series, macular thicknesses of diabetic patients with clinically significant macular edema (CSME) were measured after 7 h of fasting and repeated 2 h after breakfast. Results: Thirty six eyes of 20 diabetic patients were evaluated. The mean central subfield thickness (CST) and maximum retinal thickness (MRT) significantly decreased after meal (mean change of -10.3 ± 14.3 μm and -13.1 ± 12.7 μm, respectively, both P < 0.001). A decrease in CST and MRT values was found in 23 (63.8) and 28 (77.7) eyes, respectively, and no eye had an increase in retinal thickness measurements. Significant correlation was found between CST and MRT change and fasting thickness measurements (P = 0.001 and P = 0.01, respectively) and intraretinal cystic spaces (P = 0.001 and P = 0.03, respectively). Mean MRT change was significantly higher in the presence of subretinal fluid (P = 0.01). Conclusion: Retinal thickness measurements may change after meal. So, fasting state of diabetic patient should be considered in measurement of macular thickness of patients with CSME. © 2015 Iranian Society of Ophthalmology

Variational Calculation for the Equation of State of Nuclear Matter at Finite Temperatures

An equation of state (EOS) for uniform nuclear matter is constructed at zero and finite temperatures with the variational method starting from the realistic nuclear Hamiltonian composed of the Argonne V18 and UIX potentials. The energy is evaluated in the two-body cluster approximation with the three-body-force contribution treated phenomenologically so as to reproduce the empirical saturation conditions. The obtained energies for symmetric nuclear matter and neutron matter at zero temperature are in fair agreement with those by Akmal, Pandharipande and Ravenhall, and the maximum mass of the neutron star is 2.2 Msolar. At finite temperatures, a variational method by Schmidt and Pandharipande is employed to evaluate the free energy, which is used to derive various thermodynamic quantities of nuclear matter necessary for supernova simulations. The result of this variational method at finite temperatures is found to be self-consistent.Comment: Revised Versio

Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy

Purpose To evaluate the effect of intra-silicone injection of bevacizumab for the treatment of neovascular glaucoma (NVG) after vitrectomy for advanced proliferative diabetic retinopathy.Methods Bevacizumab was injected into the silicone oil in five pseudophakic eyes of five patients with NVG. The iris neovascularization (INV) and NVG had developed 1.5-4 months after vitrectomy and silicone oil tamponade. The main outcome measures were regression of INV, intraocular pressure and visual acuity.Results In all eyes, INV regressed and intraocular pressure was controlled within 7 days. Visual acuity improved in all eyes. In one patient, INV and NVG recurred 10 weeks after the injection and was successfully treated with a repeat intra-silicone bevacizumab injection.Conclusion Intra-silicone injection of bevacizumab is effective in the treatment of patients with INV and NVG after vitrectomy for advanced proliferative diabetic retinopathy. © 2010 Macmillan Publishers Limited All rights reserved

EEG Slow Waves in Traumatic Brain Injury: Convergent Findings in Mouse and Man

OBJECTIVE: Evidence from previous studies suggests that greater sleep pressure, in the form of EEG-based slow waves, accumulates in specific brain regions that are more active during prior waking experience. We sought to quantify the number and coherence of EEG slow waves in subjects with mild traumatic brain injury (mTBI). METHODS: We developed a method to automatically detect individual slow waves in each EEG channel, and validated this method using simulated EEG data. We then used this method to quantify EEG-based slow waves during sleep and wake states in both mouse and human subjects with mTBI. A modified coherence index that accounts for information from multiple channels was calculated as a measure of slow wave synchrony. RESULTS: Brain-injured mice showed significantly higher theta:alpha amplitude ratios and significantly more slow waves during spontaneous wakefulness and during prolonged sleep deprivation, compared to sham-injured control mice. Human subjects with mTBI showed significantly higher theta:beta amplitude ratios and significantly more EEG slow waves while awake compared to age-matched control subjects. We then quantified the global coherence index of slow waves across several EEG channels in human subjects. Individuals with mTBI showed significantly less EEG global coherence compared to control subjects while awake, but not during sleep. EEG global coherence was significantly correlated with severity of post-concussive symptoms (as assessed by the Neurobehavioral Symptom Inventory scale). CONCLUSION AND IMPLICATIONS: Taken together, our data from both mouse and human studies suggest that EEG slow wave quantity and the global coherence index of slow waves may represent a sensitive marker for the diagnosis and prognosis of mTBI and post-concussive symptoms